88 related articles for article (PubMed ID: 25496344)
1. MRI sensing of neurotransmitters with a crown ether appended Gd(3+) complex.
Oukhatar F; Même S; Même W; Szeremeta F; Logothetis NK; Angelovski G; Tóth É
ACS Chem Neurosci; 2015 Feb; 6(2):219-25. PubMed ID: 25496344
[TBL] [Abstract][Full Text] [Related]
2. Macrocyclic Gd(3+) complexes with pendant crown ethers designed for binding zwitterionic neurotransmitters.
Oukhatar F; Meudal H; Landon C; Logothetis NK; Platas-Iglesias C; Angelovski G; Tóth É
Chemistry; 2015 Jul; 21(31):11226-37. PubMed ID: 26118946
[TBL] [Abstract][Full Text] [Related]
3. A low-molecular-weight ditopic MRI probe for ratiometric sensing of zwitterionic amino acid neurotransmitters.
Toljić Đ; Angelovski G
Chem Commun (Camb); 2019 Oct; 55(79):11924-11927. PubMed ID: 31528965
[TBL] [Abstract][Full Text] [Related]
4. Novel 15-crown-5 ether or beta-diketone incorporated gadolinium complexes for the detection of potassium ions or magnesium and calcium ions.
Hifumi H; Tanimoto A; Citterio D; Komatsu H; Suzuki K
Analyst; 2007 Nov; 132(11):1153-60. PubMed ID: 17955150
[TBL] [Abstract][Full Text] [Related]
5. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
6. Strategies for sensing neurotransmitters with responsive MRI contrast agents.
Angelovski G; Tóth É
Chem Soc Rev; 2017 Jan; 46(2):324-336. PubMed ID: 28059423
[TBL] [Abstract][Full Text] [Related]
7. Lanthanide(III) complexes that contain a self-immolative arm: potential enzyme responsive contrast agents for magnetic resonance imaging.
Chauvin T; Torres S; Rosseto R; Kotek J; Badet B; Durand P; Tóth E
Chemistry; 2012 Jan; 18(5):1408-18. PubMed ID: 22213022
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and relaxometric characterization of a MRI Gd-based probe responsive to glutamic acid decarboxylase enzymatic activity.
Napolitano R; Pariani G; Fedeli F; Baranyai Z; Aswendt M; Aime S; Gianolio E
J Med Chem; 2013 Mar; 56(6):2466-77. PubMed ID: 23469759
[TBL] [Abstract][Full Text] [Related]
9. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
[TBL] [Abstract][Full Text] [Related]
11. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
[TBL] [Abstract][Full Text] [Related]
12. MRI contrast agents: basic chemistry and safety.
Hao D; Ai T; Goerner F; Hu X; Runge VM; Tweedle M
J Magn Reson Imaging; 2012 Nov; 36(5):1060-71. PubMed ID: 23090917
[TBL] [Abstract][Full Text] [Related]
13. In vivo labeling of B16 melanoma tumor xenograft with a thiol-reactive gadolinium based MRI contrast agent.
Menchise V; Digilio G; Gianolio E; Cittadino E; Catanzaro V; Carrera C; Aime S
Mol Pharm; 2011 Oct; 8(5):1750-6. PubMed ID: 21780833
[TBL] [Abstract][Full Text] [Related]
14. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
Laus S; Ruloff R; Tóth E; Merbach AE
Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of pH-sensitive, biotinylated MRI contrast agents and their conjugates with avidin.
Vibhute SM; Engelmann J; Verbić T; Maier ME; Logothetis NK; Angelovski G
Org Biomol Chem; 2013 Feb; 11(8):1294-305. PubMed ID: 23223612
[TBL] [Abstract][Full Text] [Related]
17. Facile synthesis and relaxation properties of novel bispolyazamacrocyclic Gd3+ complexes: an attempt towards calcium-sensitive MRI contrast agents.
Mishra A; Fousková P; Angelovski G; Balogh E; Mishra AK; Logothetis NK; Tóth E
Inorg Chem; 2008 Feb; 47(4):1370-81. PubMed ID: 18166011
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of calcium responsive magnetic resonance imaging agent: Its relaxation and luminescence studies.
Tanwar J; Datta A; Chauhan K; Kumaran SS; Tiwari AK; Kadiyala KG; Pal S; Thirumal M; Mishra AK
Eur J Med Chem; 2014 Jul; 82():225-32. PubMed ID: 24904969
[TBL] [Abstract][Full Text] [Related]
19. Orthogonal synthesis of a heterodimeric ligand for the development of the Gd(III)-Ga(III) ditopic complex as a potential pH-sensitive MRI/PET probe.
Vologdin N; Rolla GA; Botta M; Tei L
Org Biomol Chem; 2013 Feb; 11(10):1683-90. PubMed ID: 23360969
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging using gadolinium-based contrast agents.
Mitsumori LM; Bhargava P; Essig M; Maki JH
Top Magn Reson Imaging; 2014 Feb; 23(1):51-69. PubMed ID: 24477166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
